期刊文献+

人胰高血糖素样肽-2类似物基因串联体构建及原核细胞表达 被引量:2

Construction and Expression of Human Glucagon-like Peptide-2 Analog Multimers in Prokaryotic Cells
原文传递
导出
摘要 利用同尾酶法构建人胰高血糖素样肽-2类似物{PP-h[Gly2]GLP-2(1-35)}基因串联体重组质粒,实现目的基因在大肠杆菌中高效表达。通过PCR扩增获得PP-h[Gly2]GLP-2(1-35)基因片段,利用同尾酶BamHⅠ和BclⅠ产生相同的粘性末端,经连接、转化、筛选等操作构建其基因串联体。经DNA测序分析,成功构建PP-h[Gly2]GLP-2(1-35)的二、四、六、八拷贝基因串联体。SDS-PAGE显示,各重组菌经D-乳糖诱导后均表达目的融合蛋白,其相对分子质量与预期结果相符,目的肽含量并非随串联个数增加而明显增加,改变融合伙伴后,目的肽的表达量从0.106 g/L提高到0.372 g/L,为大量制备和纯化PP-h[Gly2]GLP-2(1-35)奠定了基础。 The multimers gene of Human Glucagon-like Peptide-2 Analog {PP-hGLP-2(1-35)} was constructed by isoaudamers and expressed high-efficiently in Eschericha.coli BL21(DE3).The PP-hGLP-2(1-35) gene was cloned by PCR,and then the multimers were constructed by a pair of isoschizomers,BamHⅠ(G^GATCC)and BclⅠ(T^GATCA),which could produce the same cohesive end(GATC).When they cut its target DNA sequence,their digested fragments could be ligated by T4 ligase and could not be excised by BamHⅠor BclⅠagain.The recombinant plasmids containing different copies of interest gene(multimers) were constructed after ligation,transformation,screening and so on.The recombinant plasmids containing 2,4,6,8 copies of interest gene(multimers) were successfully constructed respectively and analyzed by DNA sequencing.All the recombinant plasmids containing multimers could express the target protein by D-Lactose and their relative molecular mass met the expectation.The concentration of target peptide was not always increasing obviously with the number of multimers,but the concentration of target peptide increased from 0.106 g/L to 0.372 g/L,when the fusion parter was changed.It benefits for mass preparation and purification of PP-hGLP-2(1-35).
出处 《药物生物技术》 CAS CSCD 2011年第2期100-105,共6页 Pharmaceutical Biotechnology
关键词 人胰高血糖素样肽-2类似物 串联体 同尾酶 Human Glucagon-like Peptide-2 Multimers Isoschizomer
  • 相关文献

参考文献13

二级参考文献80

共引文献16

同被引文献26

  • 1朱爱华,刘文涛,鲁勇,金亮,王宇,刘景晶.P277多肽的表达、纯化及初步药效学分析[J].扬州大学学报(农业与生命科学版),2007,28(4):13-17. 被引量:2
  • 2李泰明,胡卓逸,刘景晶,马小驹,周慧,闵伟伟.N端延伸的人肠生长激素类似物基因的合成、克隆及融合表达[J].中国药科大学学报,2005,36(4):373-377. 被引量:3
  • 3Gedulin BR, Nikoulina SE, Smith PA, et al. Exenatide (Exendin-4) improves insulin sensitivity and β-Cell mass in insulin-resistant obese fa/fa zucker rats independent of glycemia and body weight. Endocrinology, 2005, 146(4): 2069-2076.
  • 4Parkes DG, Pittner R, Jodka C, et al. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism, 2001, 50(5): 583-589.
  • 5Tourrel C, Bailbe D, Meile M J, et al. Glucagon-like peptide-1 and Exendin-4 stimulate β-Cell neogenesis newborn rats resulting glucose homeostasis at 50(7): 1562-1570. in streptozotocin-treated in persistently improved adult age. Diabetes, 2001,.
  • 6Kolterman Synthetic OG, Buse Exendin-4 JB, Fineman (Exenatide) MS, et al. significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab, 2003, 88(7): 3082-3089.
  • 7Mank CM, Moore CX, Jodka CM, et al. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Int J Obes, 2006, 30(9): 1332-1340.
  • 8Hansen KB, Vilsboll T, Knop FK. Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes-a review. Diabetes Metab Syndr Obes, 2010, 3: 155-163.
  • 9Akkati S, Sam KG, Tungha G. Emergence of promising therapies in diabetes mellitus. J Clin Pharmacol, 2011, 51(6): 796-804.
  • 10Wang XC, Zu XY, Chen HG, et al. Preparation and purification Exendin-4 from Escherichia coli: China, 200810049811.5. 2009- 11-25.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部